These findings identify a novel mechanism of increased ATGL-mediated LDs utilization in colon cancer progression and establish a platform for new diagnostic and therapeutic importance in colonic tumorigenesis, especially when driven by obesity. Here, PNPLA2 is linked to malignant colon neoplasm.